Colchicine works by binding to a protein called tubulin, which cells need to build their internal scaffolding. This disrupts the ability of white blood cells to travel to sites of inflammation and release the chemicals that cause swelling and pain. It’s one of the oldest anti-inflammatory drugs still in use, prescribed primarily for gout flares, pericarditis, and a condition called familial Mediterranean fever.
How Colchicine Stops Inflammation at the Cellular Level
Every cell in your body contains tiny structural tubes called microtubules, built from pairs of proteins called tubulin. These microtubules act like a skeleton and a highway system: they hold the cell’s shape and allow it to move, divide, and transport materials internally. Colchicine binds to one half of the tubulin pair (the beta subunit) and forces it into a curved shape that can’t lock into the straight configuration needed for assembly. The result is that microtubules can’t form properly.
This matters most for neutrophils, the white blood cells that are first responders to inflammation. When uric acid crystals form in a joint during a gout flare, your body sends neutrophils rushing to the area. They squeeze through blood vessel walls, migrate to the crystal deposits, and release enzymes and inflammatory signals that cause the intense pain and swelling you feel. Every step of that process, from migration to the release of those inflammatory chemicals, depends on intact microtubules. Colchicine effectively grounds these cells, preventing them from reaching the site or doing damage once they arrive.
Blocking the Inflammation Amplifier
Beyond simply slowing down white blood cells, colchicine also interferes with a key alarm system inside immune cells called the NLRP3 inflammasome. This is a protein complex that, when activated, triggers the release of a powerful inflammatory signal called IL-1 beta. In gout, uric acid crystals are one of the triggers that switch this alarm on, creating a self-reinforcing cycle of inflammation.
Colchicine disrupts the inflammasome by preventing two of its component proteins from physically coming together inside the cell. Without that assembly step, the inflammasome can’t activate, and IL-1 beta production drops. This is a distinct mechanism from the microtubule disruption, and it helps explain why colchicine is effective in inflammatory conditions beyond gout, including pericarditis and certain cardiovascular applications where IL-1 beta plays a central role.
What Colchicine Treats
Gout flares are the most common reason colchicine is prescribed. The standard approach is 1.2 mg taken at the first sign of a flare, followed by 0.6 mg one hour later, for a total of 1.8 mg. This low-dose regimen replaced older, higher-dose protocols that caused significantly more side effects without improving outcomes. Timing matters: colchicine works best when taken within the first 12 to 24 hours of a flare. Once inflammation is fully established, it becomes less effective.
For pericarditis (inflammation of the sac around the heart), colchicine is used alongside standard anti-inflammatory treatment, typically for three to six months. People weighing under 70 kg generally take 0.5 mg once daily, while those above that threshold take 0.5 mg twice daily. Clinical trials have consistently shown it reduces the rate of recurrent pericarditis, which is the main problem patients face with this condition.
How Your Body Processes Colchicine
Colchicine is absorbed through the gut and broken down primarily by a liver enzyme called CYP3A4. A transport protein called P-glycoprotein (P-gp) plays an unusually large role in how the drug moves through your body. P-gp pumps colchicine back into the intestinal lumen, limiting how much gets absorbed. It also helps move the drug into bile for excretion through the liver and into urine through the kidneys. This means colchicine’s blood levels are heavily influenced by anything that affects these two systems.
People with significant kidney or liver impairment process colchicine more slowly, which can lead to dangerously high levels in the blood even at standard doses. The drug has a narrow therapeutic window, meaning the gap between an effective dose and a toxic dose is small. This is the main reason modern dosing is much more conservative than historical practice, when patients were sometimes told to keep taking colchicine until they developed diarrhea.
Drug Interactions Worth Knowing About
Because colchicine depends on CYP3A4 and P-gp for breakdown and elimination, any drug that blocks these pathways can push colchicine levels dangerously high. The most commonly relevant interactions involve certain antibiotics (like clarithromycin), antifungal medications, and some heart drugs. If you’re taking colchicine and are prescribed a new medication, your pharmacist should flag potential conflicts.
The interaction with statins (cholesterol-lowering drugs) deserves particular attention because both colchicine and several statins compete for the same CYP3A4 enzyme and P-gp transporter. An analysis of nearly two decades of FDA adverse event reports found that combining the two was associated with a significant signal for muscle toxicity. The risk varied by statin type. Fluvastatin and simvastatin showed the strongest association with muscle problems, while lovastatin and pitavastatin showed no detectable signal. If you take both a statin and colchicine, unexplained muscle pain or weakness is something to bring up with your prescriber promptly.
Common Side Effects
Gastrointestinal symptoms are by far the most frequent side effects. Diarrhea, nausea, and abdominal cramping occur because the cells lining your gut divide rapidly and depend on microtubules to do so. Colchicine disrupts that process in the same way it disrupts immune cell function. At modern low doses, these symptoms are usually mild and temporary. At higher doses, they become nearly universal and can be severe.
Signs of toxicity beyond GI symptoms include muscle weakness, numbness or tingling in the hands and feet, and changes in blood cell counts. These are rare at recommended doses in people with normal kidney and liver function, but they can develop insidiously in people who accumulate the drug over time due to impaired clearance. Because colchicine’s toxic effects can take days to fully manifest after an overdose, even accidental overexposure should be taken seriously.